AFRIN spray for sinusitis, runny nose and stuffy nose 0.05% /20 ml Bayer

Afrin is an effective, long-acting medicine that quickly relieves symptoms associated with nasal congestion due to colds, sinusitis, hay fever and other upper respiratory allergies. Using Afrin twice a day is usually enough to make breathing easier during the day and night. Afrin 0.05% can also be used to facilitate examination or surgery of the nose, as well as as an adjunct treatment for ear infections. Dosage: Adults and children over 10 years: 2 sprays in each nostril every 12 hours. Children 6-10 years: 1 spray in each nostril every 12 hours. Do not exceed the recommended dose and do not use for longer than 7 days, unless your doctor has prescribed otherwise. Afrin should not be administered at intervals of less than 12 hours. Application: With your head upright, insert the tip of the bottle into the nostril, without completely blocking it. Squeeze the bottle quickly and firmly to spray the recommended dose into each nostril. Clean the tip of the bottle after use. Do not use Afrin in children under 6 years of age. Active ingredient: oxymetazoline hydrochloride For a full list of ingredients, please read the leaflet. Precautions: Do not use Afrin:

if you are allergic to oxymetazoline hydrochloride or any of the other ingredients of this medicine;
if you are currently taking monoamine oxidase inhibitors (MAOIs) or have been treated with MAOIs in the last 14 days.
if you have angle-closure glaucoma;
if you have had a trans-sphenoidal hypophysectomy;
if you have inflammation of the skin and mucous membrane of the nasal vestibule and crusting (dry rhinitis);
if you have acute coronary disease or cardiac asthma;
if you have severe hypertension.

Talk to your doctor before using Afrin if you suffer from cardiovascular disorders, thyroid or prostate disease, high blood pressure, diabetes or have problems urinating. The use of oxymetazoline has not been associated with adverse pregnancy outcomes. Afrin can be used in pregnant women if recommended by a doctor. Caution should be exercised in patients with hypertension or signs of reduced placental perfusion. Frequent or prolonged use in high doses may reduce placental perfusion. It is not known whether oxymetazoline is excreted in breast milk. Due to the lack of data on the use of oxymetazoline during breastfeeding, Afrin should not be used during breastfeeding. Packaging type: Cardboard box containing a plastic bottle with 20 ml of solution. Medicinal product without a prescription. Read the package leaflet before use. Marketing Authorisation Holder: Bayer Bulgaria EOOD, 5 Rezbarska Street, 1510 Sofia, Bulgaria, tel.: +359 2 4247 280; fax: +359 2 814 01 09.